OrbiMed's investment team includes over 40 experienced professionals with expertise in the life sciences industry, finance, and law. Many have advanced degrees in science and medicine. OrbiMed's distinctive structure combines the focus of analysts dedicated to specific market sub-sectors with the synergies of public equity and private equity professionals collaborating in a seamlessly integrated platform.

OrbiMed's professionals seek an exceptional level of research intensity within our healthcare universe of over 750 publicly-traded and 2.000 privately-held companies. The team has a demonstrated record of seeking successful investments across market cycles in both public and private companies.